Literature DB >> 26368536

Insights into the binding of thiosemicarbazone derivatives with human serum albumin: spectroscopy and molecular modelling studies.

Subramani Karthikeyan1, Ganesan Bharanidharan1, Manish Kesherwani2, Karthik Ananth Mani3, Narasimhan Srinivasan3, Devadasan Velmurugan2,4, Prakasarao Aruna1, Singaravelu Ganesan1.   

Abstract

4-[(1Z)-1-(2-carbamothioylhydrazinylidene)ethyl]phenyl acetate [Ace semi],4-[(1Z)-1-(2-carbamothioylhydrazinylidene)ethyl]phenyl propanoate [Pro semi] from the family of thiosemicarbazones derivative has been newly synthesized. It has good anticancer activity as well as antibacterial and it is also less toxic in nature, its binding characteristics are therefore of huge interest for understanding pharmacokinetic mechanism of the drug. The binding of thiosemicarbazone derivative to human serum albumin (HSA) has been investigated by studying its quenching mechanism, binding kinetics and the molecular distance (r) between donor (HSA) and acceptor (thiosemicarbazone derivative) was estimated according to Forster's theory of non-radiative energy transfer using fluorescence spectroscopy. The binding dynamics has been elaborated using synchronous fluorescence spectroscopy, and the feature of thiosemicarbazone derivative induced structural changes of HSA has been studied by circular dichorism, Fourier transform infrared spectroscopy. Molecular modelling simulations explore the hydrophobic interaction and hydrogen bonding which stabilizes the interaction.

Entities:  

Keywords:  anticancer; drug-binding pocket; florescence resonance energy transfer; molecular modelling

Mesh:

Substances:

Year:  2015        PMID: 26368536     DOI: 10.1080/07391102.2015.1075905

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  5 in total

1.  In vitro and in vivo cytotoxic activity and human serum albumin interaction for a methoxy-styryl-thiosemicarbazone.

Authors:  Otávio Augusto Chaves; Isabela S de Castro; Carla Marins Goulart; Myrtes S S Bellieny; José Carlos Netto-Ferreira; Juliana Echevarria-Lima; Aurea Echevarria
Journal:  Invest New Drugs       Date:  2019-01-19       Impact factor: 3.850

2.  Domain-specific interactions between MLN8237 and human serum albumin estimated by STD and WaterLOGSY NMR, ITC, spectroscopic, and docking techniques.

Authors:  Hongqin Yang; Jiuyang Liu; Yanmei Huang; Rui Gao; Bin Tang; Shanshan Li; Jiawei He; Hui Li
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

3.  Spectroscopic and molecular modeling studies of binding interaction between bovine serum albumin and roflumilast.

Authors:  Tanveer A Wani; Ahmed H Bakheit; Mohammed Nazam Ansari; Abdul-Rahman A Al-Majed; Bakr M Al-Qahtani; Seema Zargar
Journal:  Drug Des Devel Ther       Date:  2018-08-28       Impact factor: 4.162

4.  Novel 3-chloro-6-nitro-1H-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies.

Authors:  Mohamed Mokhtar Mohamed Abdelahi; Youness El Bakri; Chin-Hung Lai; Karthikeyan Subramani; El Hassane Anouar; Sajjad Ahmad; Mohammed Benchidmi; Joel T Mague; Jelena Popović-Djordjević; Souraya Goumri-Said
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

5.  Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies.

Authors:  Hongqin Yang; Yanmei Huang; Jiuyang Liu; Peixiao Tang; Qiaomei Sun; Xinnuo Xiong; Bin Tang; Jiawei He; Hui Li
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.